A Drosophila XPD model links cell cycle coordination with neuro-development and suggests links to cancer

Karin Stettler1, Xiaoming Li1, Björn Sandrock2

  • 1Institute of Cell Biology, University of Bern, 3012 Bern, Switzerland.

Disease Models & Mechanisms
|November 29, 2014
PubMed

Insights

Developing a fly model for XPD gene mutations revealed that UV sensitivity did not correlate with cancer risk in humans. Specific XPD mutations impact transcription factor IIH stability and cell cycle control, linking them to distinct clinical phenotypes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • The XPD (ERCC2) gene is crucial for transcription, DNA repair, and cell cycle regulation.
  • Mutations in XPD cause xeroderma pigmentosum (XP), Cockayne syndrome (XP/CS), and trichothiodystrophy (TTD), with XP patients exhibiting high cancer predisposition.

Purpose of the Study:

  • To investigate the functional consequences of hypomorphic XPD alleles found in human XP-D patients using a Drosophila model.
  • To correlate specific XPD mutations with distinct clinical phenotypes, including cancer risk, developmental defects, and UV sensitivity.

Main Methods:

  • Development of a Drosophila melanogaster model for studying XPD mutations.
  • Immunoprecipitation followed by quantitative MS/MS analysis to assess TFIIH subcomplex formation and stability.
  • Microscopic analysis of chromatin and centrosome behavior during embryonic development.

Main Results:

  • Drosophila UV sensitivity did not correlate with human tumor formation predisposition for certain XPD mutations.
  • XPD mutations linked to high cancer risk showed reduced interaction with core TFIIH and abnormal interaction with the CAK complex.
  • Specific XPD alleles caused chromatin loss, free centrosomes, and cell cycle timing defects, correlating with XP/CS and TTD neurodevelopmental and growth abnormalities.

Conclusions:

  • The Drosophila model effectively recapitulates distinct aspects of XPD-related human disorders.
  • XPD mutation effects on TFIIH stability and cell cycle control are key determinants of clinical phenotype.
  • Understanding these molecular mechanisms can inform the diagnosis and potential therapeutic strategies for XPD-related diseases.

Related Concept Videos